Estimated impact of COVID-19 on preventive care service delivery: an observational cohort study

Table 1 Summarized Canadian Task Force for Preventive Health Care’s screening recommendations

Screening Type	Age (years)	Sex	Interval
Cervical Cancer [14]	25 to 69	Female	3 years
Colorectal Cancer [15]	50 to 74	Female and Male	2 years (FOBT and FIT) 10 years (sigmoidoscopy and colonoscopy)
Type 2 Diabetes^a	≥ 40	Female and Male	1 to 5 years based on risk [16] 3 years [17]

^aThe screening interval for type 2 diabetes was selected as 3 years for this study as CANRISK scores were not available [18]. This aligns with the Diabetes Canada recommendations for average risk individuals over 40 years old [17]

ISSN: 1472-6963